logo

OPRX

Optimizerx·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 6
Bearish signal 0
Consensus Rating "Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About OPRX

Optimizerx Corp.

A developer of novel, orally administered therapies for the treatment of chronic diseases, with a focus on gastrointestinal and metabolic disorders

Healthcare Technology
--
06/22/2018
NASDAQ Stock Exchange
106
12-31
Common stock
260 Charles Street Suite 302, Waltham, MA 02453
--
Optimizerx Corp. was founded in Nevada. Optimizerx is a digital health technology company that enables life science organizations, healthcare providers and patients to interact care-centered at critical moments throughout the patient care process. Optimizerx connects more than 60 percent of U.S. healthcare providers and millions of patients with an intelligent technology platform embedded in a proprietary point-of-care network, helping patients start and continue using their medicines.

Earnings Call

Company Financials

EPS

OPRX has released its 2025 Q3 earnings. EPS was reported at 0.2, versus the expected 0.05, beating expectations. The chart below visualizes how OPRX has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

OPRX has released its 2025 Q3 earnings report, with revenue of 26.07M, reflecting a YoY change of 22.33%, and net profit of 779.00K, showing a YoY change of 108.54%. The Sankey diagram below clearly presents OPRX's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime